Predictive Oncology (NASDAQ:POAI) Stock Crosses Below Two Hundred Day Moving Average After Earnings Miss

Predictive Oncology Inc. (NASDAQ:POAI)’s share price crossed below its 200-day moving average during trading on Wednesday after the company announced weaker than expected quarterly earnings. The stock has a 200-day moving average of $1.08 and traded as low as $0.74. Predictive Oncology shares last traded at $0.87, with a volume of 802,857 shares traded.

The medical instruments supplier reported ($0.22) EPS for the quarter, missing the consensus estimate of ($0.09) by ($0.13). The company had revenue of $0.00 million during the quarter, compared to analyst estimates of $1.50 million. Predictive Oncology had a negative net margin of 672.89% and a negative return on equity of 1,555.67%.

Predictive Oncology Price Performance

The company has a market cap of $8.89 million, a price-to-earnings ratio of -0.29 and a beta of 1.18. The business has a 50 day simple moving average of $0.84 and a 200 day simple moving average of $1.07.

Predictive Oncology Company Profile

Predictive Oncology Inc operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the biobank of approximately 150K tumor samples.